It was described earlier that Big Pharma controls (or trying to control) academia. If some investigation is worth to commercialize it is usually tested in start-ups and this process is of interest for Big Pharma. Absolutely logical – all potential rivals are under control. Here we have some summary of the latest activity.
No comments:
Post a Comment